RBC Capital on Acadia Pharmaceuticals (ACAD): 'shares remain fundamentally undervalued'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Wall Street tumbles as hot inflation data feeds worries about Fed rate hikes
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 19.16 +0.54 (2.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.62 | 52 Week High | $42.49 | |||
| Open | $18.60 | 52 Week Low | $16.64 | |||
| Day High | $19.16 | P/E | N/A | |||
| Day Low | $18.49 | EPS | $-0.42 | |||
| Volume | 720,545 | |||||
| ACADIA HEALTHCARE (NASDAQ: ACHC) | Delayed: 31.74 +1.51 (5.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.23 | 52 Week High | $70.84 | |||
| Open | $29.84 | 52 Week Low | $34.40 | |||
| Day High | $31.74 | P/E | 36.91 | |||
| Day Low | $29.84 | EPS | $0.86 | |||
| Volume | 838,495 | |||||
